U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C9H14N5O4P.H2O
Molecular Weight 305.2276
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of TENOFOVIR

SMILES

O.C[C@H](CN1C=NC2=C1N=CN=C2N)OCP(O)(O)=O

InChI

InChIKey=PINIEAOMWQJGBW-FYZOBXCZSA-N
InChI=1S/C9H14N5O4P.H2O/c1-6(18-5-19(15,16)17)2-14-4-13-7-8(10)11-3-12-9(7)14;/h3-4,6H,2,5H2,1H3,(H2,10,11,12)(H2,15,16,17);1H2/t6-;/m1./s1

HIDE SMILES / InChI
Molecular Formula H2O
Molecular Weight 18.0153
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE
Molecular Formula C9H14N5O4P
Molecular Weight 287.2123
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 1 / 1
E/Z Centers 0
Optical Activity UNSPECIFIED

Description
Curator's Comment: Description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/9765248 | http://www.sciencedirect.com/science/article/pii/S2211383512001402

(R)-9-(2-Phosphonylmethoxypropyl)adenine (PMPA known as tenofovir) is an antiviral drug. Diphosphate of PMPA acts as a selective inhibitor of the HIV-1 reverse transcriptase. Tenofovir disoproxil was approved for clinical use for the treatment of HIV infection (AIDS) and chronic HBV infection.

CNS Activity

Originator

Balzarini, J. et al.
22
Curator's Comment: reference retrieved from http://www.sciencedirect.com/science/article/pii/S2211383512001402

Approval Year

2001
187
Targets

Targets

Primary TargetPharmacologyConditionPotency
Inhibitor
8504
 58.0 µM [Kd]
Inhibitor
8504
 3.3 nM [EC50]
Inhibitor
8504
 3.5 nM [EC50]
Inhibitor
8504
 0.49 µM [EC50]
Inhibitor
8504
 0.3 nM [IC50]
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Approved
8583
VIREAD

Approved Use

Tenofovir disoproxil fumarate is a prescription medicine approved by the U.S. Food and Drug Administration (FDA) for the treatment of HIV and HBV infections

Launch Date

2012
Primary
Approved
8583
VIREAD

Approved Use

Tenofovir disoproxil fumarate is a prescription medicine approved by the U.S. Food and Drug Administration (FDA) for the treatment of HIV and HBV infections

Launch Date

2012
Primary
Phase II
1147
Unknown

Approved Use

Unknown
Primary
Basic research
Unknown

Approved Use

Unknown
Cmax

Cmax

ValueDoseCo-administeredAnalytePopulation
209.6 ng/mL
EXPERIMENT
https://pubmed.ncbi.nlm.nih.gov/23278367
150 mg single, oral
dose: 150 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
TENOFOVIR plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FASTED
456.7 ng/mL
EXPERIMENT
https://pubmed.ncbi.nlm.nih.gov/23278367
300 mg single, oral
dose: 300 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
TENOFOVIR plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FASTED
448.5 ng/mL
EXPERIMENT
https://pubmed.ncbi.nlm.nih.gov/23278367
300 mg single, oral
dose: 300 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
TENOFOVIR plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FED
989.8 ng/mL
EXPERIMENT
https://pubmed.ncbi.nlm.nih.gov/23278367
600 mg single, oral
dose: 600 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
TENOFOVIR plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FASTED
523.4 ng/mL
EXPERIMENT
https://pubmed.ncbi.nlm.nih.gov/23278367
300 mg 1 times / day multiple, oral
dose: 300 mg
route of administration: Oral
experiment type: MULTIPLE
co-administered:
TENOFOVIR plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FASTED
0.03 μg/mL
DRUG LABEL
https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/208464s000lbl.pdf
25 mg 1 times / day multiple, oral
dose: 25 mg
route of administration: Oral
experiment type: MULTIPLE
co-administered:
TENOFOVIR plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: UNKNOWN
food status: FED
326 ng/mL
OTHER
https://www.medicines.org.uk/emc/product/8138/smpc#PRODUCTINFO
245 mg 1 times / day multiple, oral
dose: 245 mg
route of administration: Oral
experiment type: MULTIPLE
co-administered:
TENOFOVIR serum
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: UNKNOWN
food status: FED
AUC

AUC

ValueDoseCo-administeredAnalytePopulation
2079.1 ng × h/mL
EXPERIMENT
https://pubmed.ncbi.nlm.nih.gov/23278367
150 mg single, oral
dose: 150 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
TENOFOVIR plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FASTED
3006.1 ng × h/mL
EXPERIMENT
https://pubmed.ncbi.nlm.nih.gov/23278367
300 mg single, oral
dose: 300 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
TENOFOVIR plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FASTED
3408.2 ng × h/mL
EXPERIMENT
https://pubmed.ncbi.nlm.nih.gov/23278367
300 mg single, oral
dose: 300 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
TENOFOVIR plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FED
6373.9 ng × h/mL
EXPERIMENT
https://pubmed.ncbi.nlm.nih.gov/23278367
600 mg single, oral
dose: 600 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
TENOFOVIR plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FASTED
4476.7 ng × h/mL
EXPERIMENT
https://pubmed.ncbi.nlm.nih.gov/23278367
300 mg 1 times / day multiple, oral
dose: 300 mg
route of administration: Oral
experiment type: MULTIPLE
co-administered:
TENOFOVIR plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FASTED
0.4 μg × h/mL
DRUG LABEL
https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/208464s000lbl.pdf
25 mg 1 times / day multiple, oral
dose: 25 mg
route of administration: Oral
experiment type: MULTIPLE
co-administered:
TENOFOVIR plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: UNKNOWN
food status: FED
3324 ng × h/mL
OTHER
https://www.medicines.org.uk/emc/product/8138/smpc#PRODUCTINFO
245 mg 1 times / day multiple, oral
dose: 245 mg
route of administration: Oral
experiment type: MULTIPLE
co-administered:
TENOFOVIR serum
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: UNKNOWN
food status: FED
T1/2

T1/2

ValueDoseCo-administeredAnalytePopulation
18.54 h
EXPERIMENT
https://pubmed.ncbi.nlm.nih.gov/23278367
150 mg single, oral
dose: 150 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
TENOFOVIR plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FASTED
17.56 h
EXPERIMENT
https://pubmed.ncbi.nlm.nih.gov/23278367
300 mg single, oral
dose: 300 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
TENOFOVIR plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FASTED
16.86 h
EXPERIMENT
https://pubmed.ncbi.nlm.nih.gov/23278367
300 mg single, oral
dose: 300 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
TENOFOVIR plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FED
18.92 h
EXPERIMENT
https://pubmed.ncbi.nlm.nih.gov/23278367
600 mg single, oral
dose: 600 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
TENOFOVIR plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FASTED
17.12 h
EXPERIMENT
https://pubmed.ncbi.nlm.nih.gov/23278367
300 mg 1 times / day multiple, oral
dose: 300 mg
route of administration: Oral
experiment type: MULTIPLE
co-administered:
TENOFOVIR plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FASTED
18 h
OTHER
https://www.medicines.org.uk/emc/product/8138/smpc#PRODUCTINFO
245 mg 1 times / day multiple, oral
dose: 245 mg
route of administration: Oral
experiment type: MULTIPLE
co-administered:
TENOFOVIR serum
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: UNKNOWN
food status: FED
Funbound

Funbound

ValueDoseCo-administeredAnalytePopulation
99.3%
DRUG LABEL
https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021356s042,022577s002lbl.pdf
TENOFOVIR plasma
Homo sapiens
population: UNKNOWN
age: UNKNOWN
sex: UNKNOWN
food status: UNKNOWN
99.3%
OTHER
https://www.medicines.org.uk/emc/product/8138/smpc#PRODUCTINFO
245 mg 1 times / day multiple, oral
dose: 245 mg
route of administration: Oral
experiment type: MULTIPLE
co-administered:
TENOFOVIR serum
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: UNKNOWN
food status: FED
Sourcing

Sourcing

Vendor/AggregatorIDURL
3B Scientific (Wuhan) Corp
3B2-0205
http://www.3bsc.com/index/pro_info.php?id=19561
AA Blocks
AA001EJQ
http://www.aablocks.com/goods/Goods/detail?id=AA001EJQ
Aaron Chemicals
AR001FBI
http://www.aaronchem.com/147127-20-6
abcr GmbH
AB437841
http://www.abcr.com/shop/en/AB437841
AbMole Bioscience
M5051
http://www.abmole.com/products/tenofovir.html
Acorn PharmaTech
ACN-029240
http://www.acornpharmatech.com/
Active Biopharma
ABP000917
http://www.activebiopharma.com/147127-20-6
Adooq BioScience
A10908
https://www.adooq.com/tenofovir-viread.html
AEchem Scientific Corp., USA
AE1-016163
http://www.aechemsc.com/info_products/AE1-016163.php
AHH Chemical co.,ltd
API-1191
http://www.ahhchemical.com/product/API-1191.html
AK Scientific, Inc. (AKSCI)
J90012
http://www.aksci.com/item_detail.php?cat=J90012
Alsachim
1763
http://www.alsachim.com/product-C2530-glo.bal-view.html
Angene
AGN-PC-0PZUPY
http://www.angenechemical.com/productshow/AGN-PC-0PZUPY.html
ApexBio Technology
A5275
http://www.apexbt.com/tenofovir.html
AstaTech, Inc.
34244
http://www.astatechinc.com/CPSResult.php?CRNO=35657
Aurum Pharmatech LLC
S-2389
http://www.Aurumpharmatech.com/Product/ProductDetails/S_2389
AvaChem Scientific
2678
http://www.avachem.com/productSearch.asp?2678
Axon MedChem
3157
https://www.axonmedchem.com/product/3157
BioCrick
BCC2500
http://www.biocrick.com/Tenofovir-BCC2500.html
BioSynth
Q-201787
https://www.biosynth.com/en/products/life-science/enzyme-substrates-reagents/products/Q-201787.html
BLD Pharm
BD01204701
http://www.bldpharm.com/products/107021-12-5.html
BLD Pharm
BD18435
http://www.bldpharm.com/products/147127-20-6.html
Boerchem
BC208449
http://www.boerchem.com/?product_35256.html
Capot Chemical
9452
http://www.capotchem.com/en/9452.htm
Capot Chemical
PubChem9452
http://www.capotchem.com/en/9452.htm
Chem Scene
CS-1609
http://www.chemscene.com/147127-20-6.html
Chemenu
CM110444
http://www.chemenu.com/products/CM110444
ChemMol
1032196
http://www.chemmol.com/chemmol/1032196.html
ChemMol
30108887
http://www.chemmol.com/chemmol/30108887.html
ChemMol
44003255
http://www.chemmol.com/chemmol/44003255.html
ChemMol
97900713
http://www.chemmol.com/chemmol/97900713.html
ChemReagents
80014913
http://www.chemreagents.com/Product/Product.asp?ProductID=80014913
Chemspace
CSSB00016987604
https://chem-space.com/CSSB00016987604
Chiralblock Biosciences
CB10985
http://www.chiralblock.com/products/147127-20-6.html
CSNpharm
CSN12559
https://www.csnpharm.com/products/tenofovir.html
eNovation Chemicals
D275770
https://www.enovationchem.com/ProductDetails.asp?ProductID=D275770
eNovation Chemicals
D320167
http://www.enovationchem.com/productDetails.asp?productID=D320167
iChemical
EBD47973
http://www.ichemical.com/products/147127-20-6.html?utm_source=PubChem&utm_medium=website&utm_campaign=product%20catalogs
Matrix Scientific
74030
https://www.matrixscientific.com/074030.html
MedChem Express
HY-13910
https://www.medchemexpress.com/tenofovir.html
Oakwood
77792
http://www.oakwoodchemical.com/ProductsList.aspx?CategoryID=-2&txtSearch=62966&ExtHyperLink=1
OChem
5252
http://www.ocheminc.com/index.php?act=psearch&pid=127T206
Selleck Chemicals
S1401
http://www.selleckchem.com/products/Tenofovir.html
Sigma-Aldrich
SML1795_SIGMA
https://www.sigmaaldrich.com/catalog/product/sigma/sml1795?utm_source=pubchem&utm_campaign=pubchem_2017&utm_medium=referral
Smolecule
S544915
http://www.smolecule.com/products/s544915
Smolecule
S752291
https://www.smolecule.com/products/s752291
TCI (Tokyo Chemical Industry)
T3006
http://www.tcichemicals.com/eshop/en/us/commodity/T3006/index.html
THE BioTek
bt-284194
https://www.thebiotek.com/product/inhibitors/bt-284194
THE BioTek
bt-293647
https://www.thebiotek.com/product/others/bt-293647
Tocris
3666
https://www.tocris.com/products/tenofovir_3666
Yuhao Chemical
A0500092
http://www.chemyuhao.com/147127-20-6.html
PubMed

PubMed

TitleDatePubMed
Development of hexadecyloxypropyl tenofovir (CMX157) for treatment of infection caused by wild-type and nucleoside/nucleotide-resistant HIV.
2010-07
Selective inhibition of HIV-1 reverse transcriptase by an antiviral inhibitor, (R)-9-(2-Phosphonylmethoxypropyl)adenine.
1998-10-16
Differential antiherpesvirus and antiretrovirus effects of the (S) and (R) enantiomers of acyclic nucleoside phosphonates: potent and selective in vitro and in vivo antiretrovirus activities of (R)-9-(2-phosphonomethoxypropyl)-2,6-diaminopurine.
1993-02
Patents

Patents

20080103115
22
20110021464
22
EP2440560
22
JP2011506374A
22

Sample Use Guides

In Vivo Use Guide
For hepatitis B - 5-100mg tablet
Route of Administration: Oral
In Vitro Use Guide
CMX-157 was active against all major subtypes of HIV-1 and HIV-2 in fresh human peripheral blood mononuclear cells (PBMCs) and against all HIV-1 strains evaluated in monocyte-derived macrophages, with 50% effective concentrations (EC(50)s) ranging between 0.20 and 7.2 nM.
Substance Class Chemical
Created
by admin
on Mon Mar 31 18:06:14 GMT 2025
Edited
by admin
on Mon Mar 31 18:06:14 GMT 2025
Record UNII
99YXE507IL
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
TENOFOVIR
MART.   USAN   USP-RS   VANDF  
USAN  
Official Name English
GS-1278
Preferred Name English
PMPA
Code English
[[(R)-2-(6-Amino-9H-purin-9-yl)-1-methylethoxy]methyl]phosphonic acid, monohydrate
Common Name English
TENOFOVIR [USAN]
Common Name English
TENOFOVIR [VANDF]
Common Name English
(R)-((2-(6-AMINO-9H-PURIN-9-YL)-1-METHYLETHOXY)METHYL)PHOSPHONIC ACID MONOHYDRATE
Systematic Name English
9-((R)-2-PHOSPHONOMETHOXY-PROPYL)ADENINE MONOHYDRATE
Systematic Name English
PHOSPHONIC ACID, P-(((1R)-2-(6-AMINO-9H-PURIN-9-YL)-1-METHYLETHOXY)METHYL)-, HYDRATE (1:1)
Systematic Name English
TENOFOVIR MONOHYDRATE
Common Name English
PMP-A
Code English
TENOFOVIR [MART.]
Common Name English
TENOFOVIR HYDRATE
Common Name English
TENOFOVIR [USP-RS]
Common Name English
Classification Tree Code System Code
WHO-ATC J05AR11
Created by admin on Mon Mar 31 18:06:14 GMT 2025 , Edited by admin on Mon Mar 31 18:06:14 GMT 2025
WHO-ESSENTIAL MEDICINES LIST 6.4.2.3 (FTC/TEN)
Created by admin on Mon Mar 31 18:06:14 GMT 2025 , Edited by admin on Mon Mar 31 18:06:14 GMT 2025
WHO-ATC J05AR18
Created by admin on Mon Mar 31 18:06:14 GMT 2025 , Edited by admin on Mon Mar 31 18:06:14 GMT 2025
NDF-RT N0000175656
Created by admin on Mon Mar 31 18:06:14 GMT 2025 , Edited by admin on Mon Mar 31 18:06:14 GMT 2025
NCI_THESAURUS C97452
Created by admin on Mon Mar 31 18:06:14 GMT 2025 , Edited by admin on Mon Mar 31 18:06:14 GMT 2025
FDA ORPHAN DRUG 276209
Created by admin on Mon Mar 31 18:06:14 GMT 2025 , Edited by admin on Mon Mar 31 18:06:14 GMT 2025
WHO-ESSENTIAL MEDICINES LIST 6.4.2.3 (EFV/FTC/TEN)
Created by admin on Mon Mar 31 18:06:14 GMT 2025 , Edited by admin on Mon Mar 31 18:06:14 GMT 2025
NDF-RT N0000175462
Created by admin on Mon Mar 31 18:06:14 GMT 2025 , Edited by admin on Mon Mar 31 18:06:14 GMT 2025
LIVERTOX NBK548917
Created by admin on Mon Mar 31 18:06:14 GMT 2025 , Edited by admin on Mon Mar 31 18:06:14 GMT 2025
WHO-ATC J05AR03
Created by admin on Mon Mar 31 18:06:14 GMT 2025 , Edited by admin on Mon Mar 31 18:06:14 GMT 2025
NCI_THESAURUS C1556
Created by admin on Mon Mar 31 18:06:14 GMT 2025 , Edited by admin on Mon Mar 31 18:06:14 GMT 2025
WHO-ATC J05AR17
Created by admin on Mon Mar 31 18:06:14 GMT 2025 , Edited by admin on Mon Mar 31 18:06:14 GMT 2025
Code System Code Type Description
DRUG CENTRAL
2592
Created by admin on Mon Mar 31 18:06:14 GMT 2025 , Edited by admin on Mon Mar 31 18:06:14 GMT 2025
PRIMARY
EVMPD
SUB25433
Created by admin on Mon Mar 31 18:06:14 GMT 2025 , Edited by admin on Mon Mar 31 18:06:14 GMT 2025
PRIMARY
NCI_THESAURUS
C29490
Created by admin on Mon Mar 31 18:06:14 GMT 2025 , Edited by admin on Mon Mar 31 18:06:14 GMT 2025
PRIMARY
LACTMED
Tenofovir
Created by admin on Mon Mar 31 18:06:14 GMT 2025 , Edited by admin on Mon Mar 31 18:06:14 GMT 2025
PRIMARY
FDA UNII
99YXE507IL
Created by admin on Mon Mar 31 18:06:14 GMT 2025 , Edited by admin on Mon Mar 31 18:06:14 GMT 2025
PRIMARY
ChEMBL
CHEMBL1538
Created by admin on Mon Mar 31 18:06:14 GMT 2025 , Edited by admin on Mon Mar 31 18:06:14 GMT 2025
PRIMARY
ChEMBL
CHEMBL483
Created by admin on Mon Mar 31 18:06:14 GMT 2025 , Edited by admin on Mon Mar 31 18:06:14 GMT 2025
PRIMARY
SMS_ID
100000089445
Created by admin on Mon Mar 31 18:06:14 GMT 2025 , Edited by admin on Mon Mar 31 18:06:14 GMT 2025
PRIMARY
WIKIPEDIA
TENOFOVIR
Created by admin on Mon Mar 31 18:06:14 GMT 2025 , Edited by admin on Mon Mar 31 18:06:14 GMT 2025
PRIMARY
CHEBI
134504
Created by admin on Mon Mar 31 18:06:14 GMT 2025 , Edited by admin on Mon Mar 31 18:06:14 GMT 2025
PRIMARY
CHEBI
63716
Created by admin on Mon Mar 31 18:06:14 GMT 2025 , Edited by admin on Mon Mar 31 18:06:14 GMT 2025
PRIMARY
DAILYMED
99YXE507IL
Created by admin on Mon Mar 31 18:06:14 GMT 2025 , Edited by admin on Mon Mar 31 18:06:14 GMT 2025
PRIMARY
MESH
C096918
Created by admin on Mon Mar 31 18:06:14 GMT 2025 , Edited by admin on Mon Mar 31 18:06:14 GMT 2025
PRIMARY
DRUG BANK
DB14126
Created by admin on Mon Mar 31 18:06:14 GMT 2025 , Edited by admin on Mon Mar 31 18:06:14 GMT 2025
PRIMARY
MESH
C046573
Created by admin on Mon Mar 31 18:06:14 GMT 2025 , Edited by admin on Mon Mar 31 18:06:14 GMT 2025
PRIMARY
RS_ITEM_NUM
1643601
Created by admin on Mon Mar 31 18:06:14 GMT 2025 , Edited by admin on Mon Mar 31 18:06:14 GMT 2025
PRIMARY
USAN
KK-88
Created by admin on Mon Mar 31 18:06:14 GMT 2025 , Edited by admin on Mon Mar 31 18:06:14 GMT 2025
PRIMARY
RXCUI
117466
Created by admin on Mon Mar 31 18:06:14 GMT 2025 , Edited by admin on Mon Mar 31 18:06:14 GMT 2025
PRIMARY RxNorm
CAS
206184-49-8
Created by admin on Mon Mar 31 18:06:14 GMT 2025 , Edited by admin on Mon Mar 31 18:06:14 GMT 2025
PRIMARY
PUBCHEM
21146529
Created by admin on Mon Mar 31 18:06:14 GMT 2025 , Edited by admin on Mon Mar 31 18:06:14 GMT 2025
PRIMARY
CHEBI
63625
Created by admin on Mon Mar 31 18:06:14 GMT 2025 , Edited by admin on Mon Mar 31 18:06:14 GMT 2025
PRIMARY
EVMPD
SUB04721MIG
Created by admin on Mon Mar 31 18:06:14 GMT 2025 , Edited by admin on Mon Mar 31 18:06:14 GMT 2025
PRIMARY
Related Record Type Details
Structure of TENOFOVIR ANHYDROUS
PARENT -> SALT/SOLVATE
Structure of TENOFOVIR ANHYDROUS
ANHYDROUS->SOLVATE
Related Record Type Details
Structure of TENOFOVIR ANHYDROUS
ACTIVE MOIETY
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966